Clinical manifestation of targeted drugs in individualized therapy of malignant tumors
Chu, D.-t.
Zhonghua Zhong Liu Za Zhi 32(10): 721-724
2010
ISSN/ISBN: 0253-3766 PMID: 21163058 Document Number: 638177
Document emailed within 1 workday
Related Documents
Ormenisan, C.; Kubik, M.; Legrand, S.; Kraemer, D.; Smotherman, C.; Masood, S. 2015: The potential of ki67 and p53 assessment in development of individualized targeted therapy in breast cancer patients Pathologica 107(3-4): 177-180Rob, L.; Svoboda, B.; Robová, H.; Stankusová, H.; Cwiertka, K.; Neumannová, R.; Petera, J.; Koliba, P.; Kudela, M. 2004: Guideline for gynecological malignant tumors--primary complex therapy in operable stages of malignant tumors of uterus cervix Ceska Gynekologie 69(5): 376-383
Kitada, M.; Sawaragi, I. 1996: Clinical evaluation of granisetron hydrochloride against nausea and vomiting induced by anticancer drugs for gynecological malignant tumors Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(1): 87-91
Medvedev, V.E.; Tarasiuk, B.A.; Medvetskiĭ, E.B.; Novikova, M.N.; Buchneva, L.V. 1984: Echography with targeted fine needle biopsy in the diagnosis of malignant tumors of the liver Klinicheskaia Khirurgiia 5: 23-25
Von Gumppenberg, S.; Fink, U.; Lindner, H. 1978: Therapy of malignant bone tumors. Recommendations for the therapy of malignant primary and secondary bone tumors Fortschritte der Medizin 96(31): 1542-1549
Phan, A.T.; Yao, J.C. 2008: Neuroendocrine tumors: novel approaches in the age of targeted therapy Oncology 22(14): 1617-1623; Discussion: 1623-1624, 1629
Chekhun, V.F.; Zhylchuk, V.E.; Lukyanova, N.Y.; Vorontsova, A.L.; Kudryavets, Y.I. 2009: Expression of drug resistance proteins in triple-receptor-negative tumors as the basis of individualized therapy of the breast cancer patients Experimental Oncology 31(2): 123-124
Baroncelli, G.; Buffoli, A.; La Face, B.; Tordiglione, M. 1982: Tangential pendular cobalt-therapy in the management of malignant testis tumors: a clinical evaluation after 14 years' experience La Radiologia Medica 68(7-8): 581-586
Okano, M.; Ohtake, T.; Saji, S. 2016: Combination Therapy of Molecular-Targeted Drugs for Breast Cancer -- their Potential in the Future Gan to Kagaku Ryoho. Cancer and ChemoTherapy 43(4): 398-403
Guidi, R.; Marcer, C.; Rossini, M. 1991: Usefulness of the "targeted" clinical examination in the screening of breast tumors La Radiologia Medica 81(3): 273-275
Muñoz, A.E. 2007: New strategies for a better use of peginterferon and ribavirin and new drugs with specifically-targeted antiviral therapy for chronic hepatitis C Acta Gastroenterologica Latinoamericana 37(2): 126-133
Furue, H. 1977: Drugs used in the treatment of malignant tumors Nursing Technique 23(6): 112-129
Fernández-Nogueras Jiménez, F.J.; Fernández Pérez, A.; Moreno León, J.; Fernández-Nogueras Jiménez, V. 1994: Hemifacial malignant granuloma as clinical manifestation of peripheral T-cell lymphoma Acta Otorrinolaringologica Espanola 45(5): 369-373
Vyslouzil, K.; Klementa, I.; Bednarík, J. 1996: Therapy of malignant tumors of the rectum--the extent and significance of radical surgical therapy Rozhledy V Chirurgii: Mesicnik Ceskoslovenske Chirurgicke Spolecnosti 75(11): 517-520
Tamiya, T.; Ohmoto, T.; Wei, M.X.; Breakfield, X.O.; Chiocca, E.A. 1994: Gene therapy for brain tumors: gene therapy for malignant brain tumors using prodrug-sensitivity genes (series 4) No Shinkei Geka. Neurological Surgery 22(12): 1099-1110
Velikaya, V.V.; Gribova, O.V.; Musabaeva, L.I.; Startseva, Z.A.; Simonov, K.A.; Aleinik, A.N.; Lisin, V.A. 2015: Ozone therapy for radiation reactions and skin lesions after neutron therapy in patients with malignant tumors Voprosy Onkologii 61(4): 571-574
Schmidt, S.; Wagner, U.; Oehr, P.; Krebs, D. 1992: Clinical use of photodynamic therapy in gynecologic tumor patients--antibody-targeted photodynamic laser therapy as a new oncologic treatment procedure Zentralblatt für Gynakologie 114(6): 307-311
Mäsiar, P.; Jakes, F.; Medeková, E. 1983: Diagnosis of malignant tumors. V. Metabolites of biomacromolecules (proteins and nucleic acids) in the serum and urine of the host of a malignant teratoma of the testis. Significance for diagnosis, therapy and prognosis Rozhledy V Chirurgii: Mesicnik Ceskoslovenske Chirurgicke Spolecnosti 62(5): 375-384
Durando, C. 1984: Current possibilities of the timely diagnosis, preoperative staging and prevention of malignant tumors of the ovary. A) Diagnostic problem of malignant ovarian tumors Minerva Ginecologica 36(4): 143-144
Kostron, H. 1987: Therapy of malignant brain tumors Wiener Klinische Wochenschrift 99(11): 366-369